Position in VYGR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$631,811
+$74,785 QoQ
Shares Held
163,682
+15.5% QoQ
Ownership
0.271%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in VYGR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,690,752,415 across 354 Biotechnology names. VYGR ranks #212 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in VYGR
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $631,811 | 163,682 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $557,026 | 141,737 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $554,351 | 118,705 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $355,043 | 114,162 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $327,170 | 96,796 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $568,003 | 100,177 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $541,112 | 92,498 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $576,448 | 72,876 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $620,203 | 66,617 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $562,432 | 66,639 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $575,669 | 74,280 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $808,598 | 70,620 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $539,114 | 69,924 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $426,469 | 69,913 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $413,819 | 69,902 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $413,711 | 70,002 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $658,572 | 86,427 | Shares | Defined | 2022-05-13 | |
| 2021-09-30 | $3,074 | 1,169 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $3,845 | 931 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,355 | 500 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $346,267 | 48,429 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $646,911 | 60,629 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,899,179 | 229,729 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $2,102,020 | 229,729 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||